Amy Simon
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
Amy Simon is Chief Medical Officer voor Beam Therapeutics, Inc. In het verleden bekleedde Dr. Simon de positie van Vice President-Clinical Development bij Alnylam Pharmaceuticals, Inc. Dr. Simon behaalde een bachelor aan de Harvard University en een doctoraat aan de Tufts University School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 102.735 ( 0,1% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 15-03-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Graduate School of Biomedical Sciences | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Graduate School of Biomedical Sciences |
Kies jouw editie
Alle financiële informatie op nationaal niveau